Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report

A 47-year-old man with over 10 years’ duration of ulcerative colitis treated by 5-aminosalicylic acid and intermittent topical steroids complained of acute epigastric pain. Esophagogastroduodenoscopy revealed diffuse mucosal edema with patchy redness, multiple erosions and nodularity of the stomach....

Full description

Saved in:
Bibliographic Details
Main Authors: Hironobu Takedomi, Kayoko Fukuda, Suma Inoue, Nanae Tsuruoka, Yasuhisa Sakata, Shigehisa Aoki, Motohiro Esaki
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2025-01-01
Series:Intestinal Research
Subjects:
Online Access:http://irjournal.org/upload/pdf/ir-2024-00013.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733664841138176
author Hironobu Takedomi
Kayoko Fukuda
Suma Inoue
Nanae Tsuruoka
Yasuhisa Sakata
Shigehisa Aoki
Motohiro Esaki
author_facet Hironobu Takedomi
Kayoko Fukuda
Suma Inoue
Nanae Tsuruoka
Yasuhisa Sakata
Shigehisa Aoki
Motohiro Esaki
author_sort Hironobu Takedomi
collection DOAJ
description A 47-year-old man with over 10 years’ duration of ulcerative colitis treated by 5-aminosalicylic acid and intermittent topical steroids complained of acute epigastric pain. Esophagogastroduodenoscopy revealed diffuse mucosal edema with patchy redness, multiple erosions and nodularity of the stomach. Bioptic examination revealed marked eosinophilic infiltration, confirming the diagnosis of eosinophilic gastroenteritis. Systemic steroid therapy was initiated, whereas his ulcerative colitis and eosinophilia recurred when tapering the steroid. Addition of azathioprine was ineffective, and we subsequently started vedolizumab for eosinophilic gastroenteritis and ulcerative colitis. The medication effectively improved his abdominal symptoms and esophagogastroduodenoscopy and ileocolonoscopy 1 year later revealed endoscopic improvement of both diseases with histologically decreased level of eosinophilic infiltration. Considering that eosinophils also express α4β7 integrins, vedolizumab can be a possible therapeutic candidate for eosinophilic gastroenteritis as well as ulcerative colitis.
format Article
id doaj-art-7a29903f94ec4fcf9ea9fb364fc9b8c1
institution DOAJ
issn 1598-9100
2288-1956
language English
publishDate 2025-01-01
publisher Korean Association for the Study of Intestinal Diseases
record_format Article
series Intestinal Research
spelling doaj-art-7a29903f94ec4fcf9ea9fb364fc9b8c12025-08-20T03:07:58ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002288-19562025-01-0123110711110.5217/ir.2024.000131081Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case reportHironobu Takedomi0Kayoko Fukuda1Suma Inoue2Nanae Tsuruoka3Yasuhisa Sakata4Shigehisa Aoki5Motohiro Esaki6 Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Department of Gastroenterology, Hiramatsu Hospital, Ogi, Japan Department of Gastroenterology, Hiramatsu Hospital, Ogi, Japan Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Division of Pathology, Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, JapanA 47-year-old man with over 10 years’ duration of ulcerative colitis treated by 5-aminosalicylic acid and intermittent topical steroids complained of acute epigastric pain. Esophagogastroduodenoscopy revealed diffuse mucosal edema with patchy redness, multiple erosions and nodularity of the stomach. Bioptic examination revealed marked eosinophilic infiltration, confirming the diagnosis of eosinophilic gastroenteritis. Systemic steroid therapy was initiated, whereas his ulcerative colitis and eosinophilia recurred when tapering the steroid. Addition of azathioprine was ineffective, and we subsequently started vedolizumab for eosinophilic gastroenteritis and ulcerative colitis. The medication effectively improved his abdominal symptoms and esophagogastroduodenoscopy and ileocolonoscopy 1 year later revealed endoscopic improvement of both diseases with histologically decreased level of eosinophilic infiltration. Considering that eosinophils also express α4β7 integrins, vedolizumab can be a possible therapeutic candidate for eosinophilic gastroenteritis as well as ulcerative colitis.http://irjournal.org/upload/pdf/ir-2024-00013.pdfeosinophilic gastroenteritisulcerative colitisα4β7 integrinvedolizumabcase reports
spellingShingle Hironobu Takedomi
Kayoko Fukuda
Suma Inoue
Nanae Tsuruoka
Yasuhisa Sakata
Shigehisa Aoki
Motohiro Esaki
Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
Intestinal Research
eosinophilic gastroenteritis
ulcerative colitis
α4β7 integrin
vedolizumab
case reports
title Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
title_full Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
title_fullStr Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
title_full_unstemmed Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
title_short Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
title_sort combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab a case report
topic eosinophilic gastroenteritis
ulcerative colitis
α4β7 integrin
vedolizumab
case reports
url http://irjournal.org/upload/pdf/ir-2024-00013.pdf
work_keys_str_mv AT hironobutakedomi combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT kayokofukuda combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT sumainoue combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT nanaetsuruoka combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT yasuhisasakata combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT shigehisaaoki combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport
AT motohiroesaki combinedeosinophilicgastroenteritisandulcerativecolitissuccessfullytreatedbyvedolizumabacasereport